• Necrostatin-1 (Nec-1): Reliable RIP1 Kinase Inhibition for A

  2026-05-14

  This article delivers scenario-driven, evidence-based guidance for using Necrostatin-1 (Nec-1), (R)-5-([7-chloro-1H-indol-3-yl]methyl)-3-methylimidazolidine-2,4-dione (SKU A4213) in cell viability and necroptosis assays. It addresses practical lab challenges, protocol optimization, and vendor selection, highlighting why researchers trust SKU A4213 for reproducible RIP1 kinase inhibition and robust necroptosis pathway interrogation.

• Shionone Activates Mitophagy to Counter Pulmonary Fibrosis v

  2026-05-14

  This study demonstrates that Shionone, a terpenoid from Ligularia fischeri, alleviates pulmonary fibrosis by activating PINK1-Parkin-mediated mitophagy, promoting the clearance of damaged mitochondria and reducing reactive oxygen species (ROS) accumulation. The findings reveal a novel anti-fibrotic mechanism, highlighting mitophagy as a potential therapeutic target for interstitial lung diseases.

• Ionomycin Calcium Salt: Precision Control of Ca2+ in Metasta

  2026-05-13

  Explore how Ionomycin calcium salt empowers high-fidelity calcium signaling studies in cancer metastasis models. This article uniquely bridges mechanistic insight with advanced assay design, grounding its analysis in recent breakthroughs on STIM1 regulation.

• NLRP10 Regulates Keratinocyte Survival and Barrier Function

  2026-05-13

  This study elucidates the role of NLRP10 in epidermal homeostasis, revealing its necessity for keratinocyte survival and p63-mediated differentiation in atopic dermatitis (AD). These mechanistic insights advance understanding of skin barrier dysfunction in AD and highlight NLRP10 as a promising therapeutic target.

• Palonosetron in CINV Prevention: Efficacy and Implications f

  2026-05-12

  Ruhlmann and Herrstedt's review critically examines palonosetron hydrochloride, a next-generation 5-HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV). Their synthesis of preclinical and clinical data reveals palonosetron’s superior efficacy in both acute and delayed CINV, with specific relevance for regimens involving DNA-alkylating agents such as dacarbazine.

• Tacalcitol Monohydrate: Synthetic Vitamin D3 in Oncology & S

  2026-05-12

  Tacalcitol monohydrate bridges dermatology and oncology by enabling precise modulation of gene expression through VDR/CaSR, potent NGF induction, and synergy with 5-fluorouracil. This guide translates the latest mechanistic evidence and workflow optimizations into actionable protocols for researchers seeking reproducibility and translational impact.

• CRISPR Screen Links Factor IX to CDK4/6 Inhibitor-Induced Se

  2026-05-11

  This study used a genome-wide CRISPR/Cas9 screen to uncover coagulation factor IX (F9) as a key regulator of senescence in breast cancer cells treated with CDK4/6 inhibitors like Palbociclib. The findings reveal new targets for improving antiproliferative strategies and understanding drug resistance in cancer therapy.

• Advancing Translational B-Cell Research with PCI-32765 (Ibru

  2026-05-11

  This thought-leadership article explores the mechanistic, experimental, and strategic landscape of Bruton's tyrosine kinase (BTK) inhibition using Ibrutinib (PCI-32765). Integrating recent biological insights, protocol optimization, and the product’s unique value for B-cell receptor signaling inhibition, the article provides translational researchers with an authoritative perspective on leveraging PCI-32765 across chronic lymphocytic leukemia and autoimmune models. Cited evidence, competitive analysis, and a forward-looking outlook position this piece as a definitive guide for next-generation B-cell research.

• Berberrubine Targets Vitamin K Cycle to Inhibit Thrombosis i

  2026-05-10

  This study demonstrates that berberrubine, a primary metabolite of berberine, effectively inhibits thrombosis by regulating the vitamin K catalytic cycle in mice. The integrated use of metabolomics and molecular docking identifies vitamin K epoxide reductase and γ-glutamyl carboxylase as key molecular targets, offering insights for safer antithrombotic drug development.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-05-09

  This study elucidates how upregulation of GLT-1 expression can reduce neuronal apoptosis and cognitive dysfunction following traumatic brain injury in mice by inhibiting the CB1-CREB signaling pathway. The findings highlight the mechanistic role of astrocytic glutamate regulation and cannabinoid receptor modulation in neuroprotection, offering new directions for memory impairment research.

• Gallein: Redefining GPCR βγ Inhibition in Translational Mode

  2026-05-08

  This article presents an advanced, evidence-based perspective on Gallein, a selective G protein βγ subunit inhibitor, and its transformative role in translational research. By dissecting the mechanistic underpinnings of Gβγ signaling, integrating new insights into insulin-independent glucose uptake, and benchmarking Gallein's performance against the evolving landscape of GPCR tool compounds, we provide actionable guidance for translational researchers seeking to unlock new disease-modifying strategies in cancer, immunology, and metabolic disorders.

• EF-P Phosphorylation Drives BBB Disruption in Streptococcus

  2026-05-08

  Yin et al. (2025) reveal a novel phosphorylation-dependent mechanism by which Streptococcus suis exacerbates blood–brain barrier (BBB) damage, implicating EF-P as a key substrate for serine/threonine kinase (STK) and a regulator of serine protease expression. These findings clarify the molecular pathogenesis of S. suis meningitis and suggest new directions for protein phosphorylation analysis in bacterial virulence.

• Single-Base 5hmC Mapping Reveals Rice Drought Epigenetic Dyn

  2026-05-07

  This study delivers the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, uncovering its context-dependent regulatory roles during drought adaptation. The findings clarify 5hmC’s dynamic interplay with 5-methylcytosine (5mC), highlighting implications for plant genome stability and stress-responsive gene expression.

• JNJ-26854165 (Serdemetan): Applied Workflows for p53 Pathway

  2026-05-07

  JNJ-26854165 (Serdemetan) empowers cancer researchers to dissect p53 signaling, quantify anti-proliferative effects, and enhance radiosensitization using robust in vitro and in vivo protocols. This article translates recent methodological advances into actionable workflows, with troubleshooting tips, comparative insights, and the latest performance benchmarks.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-06

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the challenge of producing high-yield, fluorescently labeled RNA probes for sensitive applications such as in situ hybridization and Northern blotting. It is designed strictly for research workflows and should not be used for diagnostic or therapeutic purposes.

472 records 13/32 page Previous Next First page 上5页 1112131415 下5页 Last page